GRM1 and neoplasm: The use of the mGluR1 agonist L-quisqualic acid reverses the antitumor effects of mGluR1 antagonists (BAY36-7620 and Riluzole) shown by the increase in cell proliferation and invasion, and the increase in tumor growth in vivo.